Shareholders

Ownership structure and shareholding information

Total: 100.00% of shares
Shareholder Name Ownership % ↓Share Count Share TypeDate
Summit Therapeutics Limited Company
36.88%
3,824,025Series A Conv Preferred12 Aug 2021
Summit Therapeutics Limited Company
32.02%
3,319,334Series B Conv Preferred12 Aug 2021
Summit Therapeutics Limited Company
15.62%
1,618,950Ordinary A12 Aug 2021
Summit Therapeutics Limited Company
12.62%
1,307,982Ord 0.0112 Aug 2021
Summit Therapeutics Limited Company
2.87%
297,377Ordinary B12 Aug 2021